Facet Hypertrophy | Diagnosis & Disease Information
Sep 12, 2022 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural wear and tear, is a process that involves cytokines and proteolytic enzymes. Other causes of facet hypertrophy can include trauma caused by car accidents, sports injuries, or falls. 1
ACR Releases 2024 Guideline Summary for Lupus Nephritis
Nov 25, 2024 · The American College of Rheumatology (ACR) has released a summary of a new guideline for the screening, treatment, and management of lupus nephritis (LN), emphasizing prompt diagnosis, personalized treatment approaches, and …
2022 ACR/AAHKS Guidelines for Management of
Apr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty: guideline summary.
Hydroxyapatite Crystal Deposition Disease (HADD)
History and Epidemiology. A typically uniarticular condition, hydroxyapatite (HA) crystal deposition disease (HADD) is marked by the presence of hydroxyapatite crystals in the periarticular soft tissues, especially the tendons 1.HA is a mineral found in normal bone, but when it builds up in and around the joints it can cause inflammation, tenderness, and pain.
Leukocytoclastic Vasculitis - Rheumatology Advisor
Aug 4, 2022 · Diagnostic Workup. The diagnostic workup for leukocytoclastic vasculitis does not follow a uniform series of steps. If the skin biopsy indicates a diagnosis of leukocytoclastic vasculitis, the goal is to determine whether there is systemic involvement and …
Undifferentiated Connective Tissue Disease - Rheumatology Advisor
Aug 9, 2022 · Undifferentiated connective tissue disease (UCTD) is a diagnosis of exclusion. Patients who present with clinical and serolotical manifestations that suggest a systemic autoimmune disease but do not fulfill criteria for defined connective tissue disease (eg, systemic lupus erythematosus, scleroderma, myositis, rheumatoid arthritis, Sjogren's syndrome) are classified to have UCTD.
Long-Term Opioid Therapy for Fibromyalgia Increases Risks for ...
Nov 26, 2024 · Long-term opioid therapy is associated with higher risks for depression and sleep disorders among patients with fibromyalgia when compared with short-term use, according to study results published in RMD Open.. While not recommended, opioids are often prescribed to patients with fibromyalgia for pain management. Opioid use has been associated with increased risks for sleep disorders ...
Drug-Induced Lupus | Diagnosis & Disease Information
Aug 4, 2022 · Epidemiology. Drug-induced lupus occurs in people who take certain types of medication but it is not considered a drug side effect. 1, 2 Flare ups caused by medications taken for pre-existing or latent lupus are excluded from this diagnosis. 1 With drug-induced lupus, specific drugs trigger an autoimmune reaction and the production of autoantibodies. 3 There are three types of drug-induced ...
Lorecivivint Shows Promising Efficacy for Managing Knee …
Nov 19, 2024 · Lorecivivint (LOR) demonstrated significant efficacy and safety for managing symptoms of moderate to severe knee osteoarthritis (OA) and improving patient reported outcomes (PROs), according to study results presented at the American College of Rheumatology (ACR) Convergence 2024, held from November 14 to 19, in Washington, DC.
Updated 2019 ACR Recommendations for Treatment of …
Sep 9, 2019 · Based on new evidence and an expert consensus, the American College of Rheumatology (ACR), the Spondylitis Association of America, and the Spondyloarthritis Research and Treatment Network released updated recommendations for the treatment of axial spondyloarthritis (SpA), which comprises ankylosing spondylitis (AS) and …